Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Back to (new) normality-A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2.
Jereczek-Fossa BA, Pepa M, Marvaso G, Isaksson JL, Soatti CP, Cazzaniga LF, Ivaldi GB, Amadori M, Antognoni P, Arcangeli S, Buffoli A, Beltramo G, Bignardi M, Bracelli S, Bruschieri L, Castiglioni S, Catalano G, Di Muzio N, Fallai C, Fariselli L, Filippi AR, Gramaglia A, Italia C, Lombardi F, Magrini SM, Nava S, Orlandi E, Pasinetti N, Sbicego EL, Scandolaro L, Scorsetti M, Stiglich F, Tortini R, Valdagni R, Vavassori V, Tonoli S, Palazzi MF; CODRAL (Board of Directors of Radiation Oncology Departments in Lombardy) network and of AIRO-L (Italian Association of Radiotherapy and Clinical Oncology – Lombardy). Jereczek-Fossa BA, et al. Among authors: pasinetti n. Med Oncol. 2020 Nov 4;37(11):108. doi: 10.1007/s12032-020-01434-1. Med Oncol. 2020. PMID: 33150476 Free PMC article.
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: Evolving technical choices and survival.
Tonoli S, Magrini SM, Costa L, Paiar F, Simontacchi G, Scotti V, Pasinetti N, Barca R, Barbieri D, De Stefani A, Cellai E, Buglione M, Biti G. Tonoli S, et al. Among authors: pasinetti n. Radiol Med. 2012 Jun;117(4):690-714. doi: 10.1007/s11547-011-0755-9. Epub 2011 Nov 17. Radiol Med. 2012. PMID: 22095424
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part II: Evolving technical choices and toxicity patterns.
Magrini SM, Tonoli S, Costa L, Pasinetti N, Paiar F, Livi L, Simontacchi G, Meattini I, Pegurri L, Borghetti P, Frata P, Ponticelli P, Buglione M, Biti G. Magrini SM, et al. Among authors: pasinetti n. Radiol Med. 2012 Jun;117(4):715-24. doi: 10.1007/s11547-011-0756-8. Epub 2011 Nov 17. Radiol Med. 2012. PMID: 22095425
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis.
Buglione M, Pedretti S, Gipponi S, Buttolo L, Panciani P, Poliani PL, Liserre R, Borghetti P, Pegurri L, Costa L, Triggiani L, Pasinetti N, Ghirardelli P, Pandini S, Padovani A, Magrini SM; Neuro-Oncology Group, Spedali Civili Hospital and Brescia University. Buglione M, et al. Among authors: pasinetti n. Radiol Med. 2015 Dec;120(12):1146-52. doi: 10.1007/s11547-015-0542-0. Epub 2015 Apr 28. Radiol Med. 2015. PMID: 25917339
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program.
Buglione M, Ghirardelli P, Triggiani L, Pedretti S, Pasinetti N, De Bari B, Tonoli S, Borghetti P, Spiazzi L, Magrini SM. Buglione M, et al. Among authors: pasinetti n. Rep Pract Oncol Radiother. 2015 Jul-Aug;20(4):284-91. doi: 10.1016/j.rpor.2015.03.003. Epub 2015 Apr 8. Rep Pract Oncol Radiother. 2015. PMID: 26109916 Free PMC article.
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease.
Costa L, Pedretti S, Foscarini F, Maddalo M, Pegurri L, Pasinetti N, Cavagnini R, Ciccarelli S, Tonoli S, Magrini SM, Buglione M. Costa L, et al. Among authors: pasinetti n. Radiol Med. 2016 Jan;121(1):70-9. doi: 10.1007/s11547-015-0565-6. Epub 2015 Aug 1. Radiol Med. 2016. PMID: 26231252
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial.
Magrini SM, Buglione M, Corvò R, Pirtoli L, Paiar F, Ponticelli P, Petrucci A, Bacigalupo A, Crociani M, Lastrucci L, Vecchio S, Bonomo P, Pasinetti N, Triggiani L, Cavagnini R, Costa L, Tonoli S, Maddalo M, Grisanti S. Magrini SM, et al. Among authors: pasinetti n. J Clin Oncol. 2016 Feb 10;34(5):427-35. doi: 10.1200/JCO.2015.63.1671. Epub 2015 Dec 7. J Clin Oncol. 2016. PMID: 26644536 Clinical Trial.
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer.
Buglione M, Maddalo M, Corvò R, Pirtoli L, Paiar F, Lastrucci L, Stefanacci M, Belgioia L, Crociani M, Vecchio S, Bonomo P, Bertocci S, Borghetti P, Pasinetti N, Triggiani L, Costa L, Tonoli S, Grisanti S, Magrini SM. Buglione M, et al. Among authors: pasinetti n. Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):462-472. doi: 10.1016/j.ijrobp.2016.10.011. Epub 2016 Oct 20. Int J Radiat Oncol Biol Phys. 2017. PMID: 27986347 Clinical Trial.
55 results